Public disclosures
Cobo Marc
Company insiders · Principal Accounting Officer · BridgeBio Oncology Therapeutics, Inc.
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-17.Following & alerts
- Reported transaction lines
- 1
- Buy lines
- 0
- Sell lines
- 1
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-111
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Cobo Marc Principal Accounting Officer · BridgeBio Oncology Therapeutics, Inc. | BBOT BridgeBio Oncology Therapeutics, Inc. | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 13734 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on July 24, 2026. | 2026-11-13 | 2026-11-17 | ≈ $184.86 78 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.
Advertisement